Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

ACE Inhibitors Companies

ACE (Angiotensin-Converting Enzyme) inhibitors are a class of medications commonly used to treat conditions such as hypertension (high blood pressure), heart failure, and certain cardiovascular diseases. Several pharmaceutical companies globally have been involved in the development, manufacturing, and distribution of ACE inhibitors.

ACE Inhibitors Key Companies Latest ACE Inhibitors Companies Update:

Pfizer (US) Focused on promoting their ACE inhibitor Accuretic® (quinapril/hydrochlorothiazide) for its proven efficacy in managing hypertension and heart failure. Partnered with healthcare providers to implement medication adherence programs for patients taking ACE inhibitors.

Novartis (Switzerland) Received FDA approval for Entresto® (sacubitril/valsartan) to treat heart failure with reduced ejection fraction, offering an alternative to traditional ACE inhibitors. Continued research on Entresto® for expanding its use in other cardiovascular conditions.

AstraZeneca (UK) Emphasized the safety and efficacy of their ACE inhibitor Altace® (ramipril) for hypertension and heart failure, highlighting its long-standing presence in the market. Collaborated with research institutions to explore new applications of ACE inhibitors for neurodegenerative diseases.

Teva Pharmaceutical Industries (Israel) Leveraged their strong position in generic drug manufacturing to offer affordable ACE inhibitor options, increasing market accessibility. Focused on developing innovative drug delivery systems for ACE inhibitors to improve patient compliance and enhance medication effectiveness.

American Heart Association (AHA) Updated their clinical practice guidelines for hypertension management, emphasizing the continued relevance of ACE inhibitors as a first-line treatment option for many patients. Provided educational resources and patient advocacy programs to raise awareness about hypertension and importance of medication adherence.

List of ACE Inhibitors Key companies in the market

Pfizer Inc.

AstraZeneca Pharmaceutical Company

Novartis AG

Johnson and Johnson Services

United Therapeutics Corporation

Merck KGaA

Teva Pharmaceutical Industry

Sandoz AG

Novartis AG

Bayer AG

Sanofi

ACE Inhibitors Market Highlights:

ACE Inhibitors Market Size

ACE Inhibitors Market Trends

ACE Inhibitors Market Analysis

ACE Inhibitors Market Share

ACE Inhibitors Market Highlights:

ACE Inhibitors Market Trends

ACE Inhibitors Market Analysis

ACE Inhibitors Market Share

ACE Inhibitors Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.